AngioGuard Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

AngioGuard General Information

Description

Developer of embolic containment technology. The company has developed containment technology designed to protect the heart and brain from embolic particles potentially dislodged during interventional medical procedures.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Plymouth, MN
  • United States
Primary Industry
Surgical Devices
Acquirer
Cordis
Vertical(s)
Life Sciences
Corporate Office
  • Plymouth, MN
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AngioGuard Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 07-Jul-1999 Completed Product Development
1. Early Stage VC Completed
To view AngioGuard’s complete valuation and funding history, request access »

AngioGuard Patents

  • 21

    Total Documents Applications and Grants

  • Total Patents Families

  • 7

    Granted

  • Pending

  • Expiring in next 12 mo

AngioGuard Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-7229463-B2 Vascular filter system for cardiopulmonary bypass Inactive 30-Jul-1999
US-7229462-B2 Vascular filter system for carotid endarterectomy Inactive 30-Jul-1999
US-6632182-B1 Multiple bit, multiple specimen endoscopic biopsy forceps Inactive 23-Oct-1998
DE-69943211-D1 Vascular filter arrangement Inactive 21-Sep-1998
EP-1043954-A1 Vascular filter system Active 21-Sep-1998 A61F2/013
To view AngioGuard’s complete patent history, request access »

AngioGuard Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aphelion Capital Venture Capital Minority
SightLine Partners Growth/Expansion Minority
To view AngioGuard’s complete investors history, request access »

Ready to get started?

Request a free trial

AngioGuard FAQs

  • When was AngioGuard founded?

    AngioGuard was founded in 1997.

  • Where is AngioGuard headquartered?

    AngioGuard is headquartered in Plymouth, MN.

  • What industry is AngioGuard in?

    AngioGuard’s primary industry is Surgical Devices.

  • Is AngioGuard a private or public company?

    AngioGuard is a Private company.

  • What is AngioGuard’s current revenue?

    The current revenue for AngioGuard is .

  • Who are AngioGuard’s investors?

    Aphelion Capital and SightLine Partners have invested in AngioGuard.

  • When was AngioGuard acquired?

    AngioGuard was acquired on 07-Jul-1999.

  • Who acquired AngioGuard?

    AngioGuard was acquired by Cordis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »